212 | Balancing Innovation and Investment while Building a Consulting Firm with Brandon Allgood from Obsidian Scientific
Failing to Success · Chad Kaleky
Audio is streamed directly from the publisher (pdcn.co) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
💡 Key Talking Points:
- Hiring the Right CEO: Brandon Allgood's experience highlights the importance of finding a CEO who understands your technology and can communicate its value effectively, especially when dealing with complex industries like pharma.
- Balancing Innovation and Investment: The challenge of startups lies in finding the right balance between developing a technology platform and pushing forward with specific programs. Startups need capital for both aspects.
- Building a Consulting Firm: After a successful career in AI and healthcare, Brandon started Obsidian Scientific to help pharmaceutical companies, venture capitalists, and startups navigate AI strategies and solutions.
➡️ Book a Call with Chad
📝 Episode Summary:
In this episode 212 of "Failing to Success", Brandon Allgood, owner of Obsidian Scientific, shares his journey in the AI and healthcare industry. He discusses the critical lesson of hiring the right CEO, emphasizing the importance of technical understanding and communication skills. Brandon also highlights the challenge of balancing innovation with investment in startups and the need for a well-thought-out business model. Finally, he talks about his latest venture, Obsidian Scientific, where he offers consulting services to guide others through the complexities of AI strategies and solutions in the pharmaceutical sector.
SUBSCRIBE TO THE PODCAST ON YOUTUBE
Listen on:
Add us on:
CEO hiring, startup challenges, AI in healthcare, business strategies, consulting firm, innovation and investment, pharmaceutical industry, AI consulting, entrepreneurship, career journey, healthcare technology, successful exit strategies, technology startups, venture capital opportunities